Endoscopy Devices Global market - Forecast to 2028

Publishing Date : October, 2021
Report Code : HCMD 0104
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Endoscopy is a minimally invasive or non-invasive medical procedure that utilizes specialized devices like endoscopes for the detailed inspection or assessment, and manipulation or treatment of diseased organs or tissues by visualizing the internal organ or area of interest. The constantly advancing various emergency or elective endoscopy procedures are being used for the timely diagnosis, and minimally-traumatic treatment of various chronic ailments like cancer, arthritis, joint injuries, inflammatory bowel diseases (IBD), chronic pancreatitis, obesity, Barrett’s esophagus, and others.

As estimated by IQ4I analysis, the endoscopy devices global market is expected to reach $39,475.6 million by 2028 growing at a high single digit CAGR from 2021 to 2028 due to persistently escalating prevalence, and incidence of chronic diseases across the globe, and the need for early diagnostic, and therapeutic interventions, increasing inclination of patients towards the minimally invasive therapeutic procedures, gradual transition of endoscopy devices market towards single-use endoscopes, the emergence of technologically advanced endoscopy products, the trend of acquisitions, and collaborations in the endoscopy device industry, and the increasing awareness, and adoption of the highly beneficial endoscopic procedures across the emerging nations.

The endoscopy devices global market is categorized into various market segments based on the product, application, end-users, and geography. Based on the type of endoscopy products, the market is segmented into endoscopes, endoscopic instruments, and endoscopic accessories. Among these, the Endoscopic Instruments segment held the largest share in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the increasing popularity of image-guided endoscopic surveillance, diagnostic, and therapeutic procedures to reduce morbidity, and mortality associated with the highly prevalent chronic diseases across the globe, and the necessity of the various endoscopy instruments to ensure the efficiency, safety, and completeness of an endoscopy procedure. Endoscopes segment is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the escalating demand for timely, and precise minimally invasive or non-invasive diagnostic, and therapeutic procedures from the large chronic disease patient pool across the globe, various technological, and fabrication advancements in endoscopes that are constantly expanding their diagnostic, and therapeutic application spectrum. Based on the product type, endoscopes have been further segmented into flexible endoscopes, rigid endoscopes, robot-assisted endoscopes, and AI-enhanced endoscopes, and capsule endoscopes. Among these, the Rigid Endoscopes segment occupy a major share in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028 due to increased utilization of rigid endoscopes for performing the highly popular endoscopic diagnostic, and therapeutic procedures like laparoscopy, arthroscopy, ENT endoscopy, and neuroendoscopy procedures, and the potential of rigid endoscopes to offer the best resolution, optical amplification, and larger field of view to perform various endoscopic procedures efficiently, and safely. Robot-Assisted Endoscopes, and artificial intelligence (AI) powered endoscopes segment is expected to be the fastest emerging segment growing with a double digit CAGR from 2021 to 2028 due to the emergence of several Robot Assisted Endoscopes, and AI guided endoscopy systems in the market, and the promising potential of robot-assisted endoscopes, and AI-enhanced endoscopy systems to mitigate the labor intensity of endoscopic procedures, and increase the precision, and safety of endoscopic procedures. Endoscopic instruments are further grouped into endoscopic cameras, digital documentation systems, light sources, monitors, and display systems, video converters, and processors, fluid management systems, and other endoscopic instruments comprised of insufflators, endoscopic ultrasound probes, and processors. Among the various endoscopic instruments, the Monitors, and display systems segment occupies a major share of revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the increasing utilization of highly accurate, and real-time images or videos to arrive at the optimum or error-free diagnostic conclusions, and to provide better clarity of the complex anatomical details to improve the precision, task efficiency, and productivity of surgeons during endoscopic therapeutic procedures, availability of technologically advanced monitors, and display units, and increasing popularity of image-guided minimally invasive endoscopic diagnostic, and therapeutic interventions among the masses. The digital documentation systems segment is expected to be the fastest-growing segment growing with a high single digit CAGR from 2021 to 2028 due to the increasing recognition of the importance of endoscopic image documentation or recording process as an integral aspect of endoscopy procedures to ensure the quality, safety, productivity, completeness, and efficiency of endoscopic procedures, and the various guidelines of major endoscopic societies like European Society of Gastrointestinal Endoscopy (ESGE), and American Society of Gastrointestinal Endoscopy (ASGE) that recommend systematic photo recording or documentation of endoscopy procedures, the necessity of digitalized documents to address or satisfy the concerns of the insurance providers, legal institutions, patients, and hospital trusts, and need of digital documents to guide future therapeutic decisions, and persistent technological advancements in the digital documentation systems. Endoscopic accessories are further classified into product types like biopsy forceps, graspers, snares, Trocars, surgical dissectors, and other accessories like endoscopic ultrasound needles, light cables, cytology brushes, bite-blocks, cleaning brushes, needle holders, retractors, endoscopic caps, and hoods, endoscopy masks. Among the various endoscopic accessories, the trocars segment occupy the largest share of revenue in 2021, and is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the necessity of the channel created by a trocar for the safer advancement or passage of endoscopes, and other equipment to internal body cavities through the smaller incisions with low insertion force, and without tearing, scarring or ripping off the surrounding fragile tissues or organs during endoscopy procedures.

The global endoscopy devices market based on applications has been classified into Arthroscopy, Pulmonary endoscopy, Laparoscopy, ENT endoscopy, Gastrointestinal endoscopy, Gynecology or obstetrics endoscopy, Neuroendoscopy, Urological endoscopy, and other Endoscopic applications consisting of cardiopulmonary endoscopy, dental endoscopy, ophthalmology endoscopy, and breast endoscopy. Among these, the Gastrointestinal endoscopy segment occupied the largest market share in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the persistently increasing prevalence of chronic diseases of the digestive tract, and the potential of gastrointestinal endoscopy to provide accurate diagnostic, and therapeutic solutions, increasing popularity of endoscopic surveillance as a preventive strategy for gastrointestinal cancer-associated morbidity, and mortality, and the ever-expanding diagnostic, and therapeutic application spectrum of gastrointestinal endoscopy procedures. The laparoscopy segment is the fastest emerging segment growing at a double digit CAGR from 2021 to 2028 due to the steadily escalating prevalence of chronic diseases of the digestive system, female reproductive system, and urinary tract system, and the potential of laparoscopy to provide accurate diagnostic, and therapeutic solutions, and the increasing research, and development activities leading to the emergence of numerous technologically advanced, patient-friendly, cosmetically advantageous laparoscopic procedures. The arthroscopy market is further segmented into knee arthroscopy, shoulder arthroscopy, wrist arthroscopy, ankle arthroscopy, elbow arthroscopy, hip arthroscopy, and other arthroscopy procedures consisting of spinal arthroscopy, and temporomandibular joint arthroscopy. Among these, the knee arthroscopy segment accounted for the largest revenue in 2021, and is expected to grow at a double digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of knee joint injuries especially related to sports, and increasing adoption of arthroscopy to provide premium diagnostic, and accurate therapeutic solutions. The hip arthroscopy segment is the fastest emerging segment growing at a double digit CAGR during the forecasted period due to the ever-escalating prevalence of hip injuries associated with sports or accidents, increasing popularity of hip arthroscopy procedures across the globe, and the increasing research focus for the development of more efficient, and safer hip arthroscopy products. The pulmonary endoscopy market is further classified into bronchoscopy, thoracoscopy, and mediastinoscopy. Among these, the bronchoscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the persistently escalating prevalence of chronic diseases of the lungs or bronchi, increasing utilization of bronchoscopy to provide premium diagnostic, and accurate therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of bronchoscopy, and the increasing research focus for the development of more efficient, and safer bronchoscopy products. The ENT endoscopy market is further categorized into nasal endoscopy, laryngoscopy, otoendoscopy, and transnasal endoscopy procedures. Among these, the nasal endoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the constantly escalating prevalence of chronic diseases associated with nasal cavity, and sinus passages, and increasing adoption of nasal endoscopy to provide optimum diagnostic, and therapeutic solutions. The laryngoscopy segment is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the ever elevating prevalence of chronic diseases associated with throat, larynx, and salivary gland, increasing popularity of laryngoscopy procedures across the globe, and the increasing research focus for the development of more efficient, and laryngoscopy products. The gastrointestinal endoscopy market is further segmented into Esophagogastroduodenoscopy, enteroscopy, colonoscopy, sigmoidoscopy, proctoscopy, and Cholangiopancreatoscopy procedures. Among these, the esophagogastroduodenoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR during the forecasted period due to the persistently escalating chronic diseases affecting the esophagus, stomach, duodenum, increasing adoption of esophagogastroduodenoscopy to provide optimized, and timely diagnostic, and therapeutic solutions, and the emergence of more efficient, and safer technologically advanced esophagogastroduodenoscopy products. The colonoscopy segment is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the ever-increasing prevalence of chronic diseases of the colon, and rectum, increasing adoption, and implementation of colonoscopic surveillance as a preventive strategy for colorectal cancer-associated morbidity, and mortality across the globe, and the increasing research focus for the development of more efficient, and colonoscopy products. The gynecological/obstetrics endoscopy market is further classified into Hysteroscopy, Colposcopy, Falloposcopy, and others comprised of amnioscopy, and fetoscopy procedures. Among these, the hysteroscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the steadily escalating prevalence of endocervical or intrauterine diseases, increasing utilization of hysteroscopy to provide precise diagnostic, and therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of hysteroscopy, and the increasing research focus for the development of more efficient, and safer hysteroscopy products. The neuroendoscopy market is further subdivided into epiduroscopy or spinal endoscopy, Intraventricular neuroendoscopy, Transcranial neuroendoscopy, and Transnasal neuroendoscopy procedures. Among these, the intraventricular neuroendoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of ventricular system associated diseases, and increasing adoption of intraventricular neuroendoscopy to provide accurate diagnostic, and accurate therapeutic solutions. The transcranial neuroendoscopy segment is the fastest emerging segment growing at a high single digit CAGR during the forecasted period due to the ever-escalating prevalence of anterior skull base region associated diseases, increasing popularity of transcranial neuroendoscopy procedures across the globe, and the increasing research focus for the development of more efficient, and safer transcranial neuroendoscopy products. The urological endoscopy market is further categorized into Nephroscopy, Cystoscopy, ureteroscopy, and resectoscopy procedures. Among these, the ureteroscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the constantly elevating prevalence of chronic diseases associated with ureters, and kidney, increasing utilization of ureteroscopy to provide unerring diagnostic, and therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of ureteroscopy, and the increasing research focus for the development of more efficient, and safer ureteroscopy products. Laparoscopic procedures are further classified into laparoscopic bariatric surgery, cholecystectomy, appendectomy, hernia repair, and hand-assisted laparoscopic procedures. Among these, the laparoscopic cholecystectomy segment accounted for the largest revenue in 2021, and is expected to grow at a double digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of gall bladder disorders, and increasing adoption of laparoscopic cholecystectomy to provide explicit diagnostic, and therapeutic solutions. The laparoscopic bariatric surgery segment is the fastest emerging segment growing at a double digit CAGR during the forecasted period due to the ever-escalating prevalence of obesity across the globe, increasing popularity of laparoscopic bariatric surgery across the globe, and the increasing research focus for the development of more efficient, and safer laparoscopic bariatric surgery products.

Based on the end-users, the endoscopy devices global market has been segmented into Hospitals, Endoscopy Ambulatory surgery centers (EASCs), Endoscopy Diagnostic Centers, and others consisting of Academic or Research Institutes, and Office based Endoscopy (OBE) suites. Among the various end-users, the Hospitals segment is the largest, and fastest emerging end-user and is expected to grow at a high single digit CAGR during the forecasted period due to the increased utilization of advanced endoscopy products in these clinical settings, the presence of a large number of sophisticated hospitals in the developed nations, and the constantly increasing number of hospitals with advanced infrastructural facilities in the developing nations.

The endoscopy devices global market is divided into four major geographies namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (ROW). Among these, North America occupied the largest share in the 2021 endoscopy devices global market, and is expected to grow at a mid single digit CAGR during the forecasted period. Persistently elevating chronic disease patient burden in the region, and elevating demand for the early diagnosis, and treatment of these diseases, escalating geriatric population burdened with numerous kinds of chronic diseases in the region, the increasing inclination, and adoption of technologically advanced diagnostic procedures, and minimally invasive therapeutic procedures by the patients of the region, availability of well-developed healthcare infrastructural facilities in the region, presence of several major endoscopy device companies in the region, and their increasing R&D investments in the region for the development of innovative, efficient, and safer endoscopy products, and a conducive regulatory, and reimbursement scenario in the region promoting the adoption of single-use endoscopes in the region are some of the factors that are propelling the endoscopy devices market growth in the region. Asia-Pacific region is the fastest emerging region and is expected of growing at a high single digit CAGR from 2021 to 2028. Steadily escalating chronic disease patient population in the region, and increasing demand for the prompt diagnosis, and treatment of these diseases, elevating geriatric population crippled with numerous kinds of chronic diseases in the region, increasing awareness, and demand for technologically advanced diagnostic procedures, and minimally invasive therapeutic procedures by the patients of the region, developing healthcare infrastructural facilities in the region, medical tourism prospects of some of the countries in the region, presence of several major endoscopy device companies in the region, and their increasing R&D investments for the development of innovative, efficient, and safer endoscopy products, presence of several domestic companies in the region offering endoscopy products at competitive prices, growing economies, and improving reimbursement scenario of these regions are some of the factors that are boosting the endoscopy devices market in the region

The endoscopy devices global market is a competitive market with more than half of the market being occupied by the top six players. Some of the key players of the endoscopy devices market are Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), Stryker Corporation (U.S.), Karl Storz SE & Co KG (Germany), Johnson & Johnson (U.S.), and Medtronic PLC (Ireland), Arthrex Inc. (U.S.), B. Braun Melsungen AG (Germany), Fujifilm Holdings Corporation (Japan), Hoya Corporation (Japan), and other Arthrex Inc. (U.S.), B. Braun Melsungen AG (Germany), Fujifilm Holdings Corporation (Japan), Hoya Corporation (Japan), and others.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • Germany
  • France
  • U.K.
  • Rest of Europe
  • Asia-Pacific 
  • China
  • Japan
  • India
  • Rest of APAC
  • Rest of the World (ROW)
  • Brazil
  • Rest of LATAM
  • The Middle East and Others
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN, AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS, AND OPPORTUNITIES
        • 3.3.1.1     PERSISTENTLY ESCALATING INCIDENCE, AND PREVALENCE OF CHRONIC DISEASES, AND THE NEED FOR EARLY DIAGNOSIS, AND TREATMENT
        • 3.3.1.2     INCREASING INCLINATION TOWARDS MINIMALLY INVASIVE THERAPEUTIC PROCEDURES
        • 3.3.1.3     THE GRADUAL ENDOSCOPY MARKET CONVERSION FROM REUSABLE TO SINGLE-USE ENDOSCOPES
        • 3.3.1.4     THE EMERGENCE OF TECHNOLOGICALLY ADVANCED ENDOSCOPY PRODUCTS
        • 3.3.1.5     PERSISTENTLY ELEVATING GERIATRIC POPULATION WITH CHRONIC DISEASES
        • 3.3.1.6     ACQUISITIONS AND COLLABORATIONS TO OPEN AN ARRAY OF OPPORTUNITIES FOR THE MARKET TO FLOURISH
        • 3.3.1.7     MARKET EXPANSION OPPORTUNITIES IN EMERGING NATIONS
      • 3.3.2     RESTRAINTS, AND THREATS
        • 3.3.2.1     HIGH COST OF THE ENDOSCOPY DEVICES, AND PROCEDURES
        • 3.3.2.2     LACK OF SKILLED, AND TRAINED PROFESSIONALS
        • 3.3.2.3     INCREASING CONCERNS ABOUT THE ADVERSE EFFECTS ASSOCIATED WITH ENDOSCOPIC PROCEDURES
        • 3.3.2.4     STRINGENT REGULATORY BODIES GUIDING THE ENDOSCOPY DEVICE MANUFACTURERS
        • 3.3.2.5     THE THREAT OF NON-INVASIVE DIAGNOSTIC, AND THERAPEUTIC TECHNOLOGIES
        • 3.3.2.6     UNFAVORABLE REIMBURSEMENT SCENARIO FOR THE ENDOSCOPY PROCEDURES
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 13485 MEDICAL DEVICES
        • 3.4.1.3     ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
      • 3.4.2     THE U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     JAPAN
      • 3.4.6     CHINA
      • 3.4.7     INDIA
    • 3.5     REIMBURSEMENT SCENARIO
      • 3.5.1     REIMBURSEMENT TABLE
    • 3.6     TECHNOLOGICAL ADVANCEMENTS
      • 3.6.1     THERAPEUTIC CAPSULE ENDOSCOPES WITH ACTIVE LOCOMOTION
      • 3.6.2     MOLECULAR ENDOSCOPIC IMAGING (MEI)
      • 3.6.3     VARIABLE STIFFNESS ENDOSCOPES, AND SHAPE LOCKING DEVICES OR OVERTUBES
      • 3.6.4     MINIATURIZED ENDOSCOPES
      • 3.6.5     3D ENDOSCOPES
      • 3.6.6     NOTES, AND LESS
      • 3.6.7     ADVANCED DIAGNOSTIC IMAGING TECHNIQUES
    • 3.7     CLINICAL TRIALS
    • 3.8     ENDOSCOPES – FDA, AND CE REGULATORY APPROVAL ANALYSIS
    • 3.9     PATENT ANALYSIS
    • 3.10     SINGLE-USE ENDOSCOPES MARKET
    • 3.11     AUTOMATED ENDOSCOPE REPROCESSORS (AER) MARKET
    • 3.12     REFURBISHED ENDOSCOPY DEVICES MARKET
    • 3.13     PORTER’S FIVE FORCE ANALYSIS
      • 3.13.1     THREAT OF NEW ENTRANTS
      • 3.13.2     THREAT OF SUBSTITUTES
      • 3.13.3     BARGAINING POWER OF SUPPLIERS
      • 3.13.4     BARGAINING POWER OF BUYERS
      • 3.13.5     COMPETITIVE RIVALRY
    • 3.14     SUPPLY CHAIN ANALYSIS
    • 3.15     AVERAGE SELLING PRICE (ASP) OF SELECT ENDOSCOPY DEVICES
    • 3.16     IMPACT OF COVID-19 ON ENDOSCOPY DEVICES INDUSTRY
    • 3.17     MARKET SHARE ANALYSIS
      • 3.17.1     ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
      • 3.17.2     ARTHROSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
      • 3.17.3     PULMONARY ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
      • 3.17.4     LAPARPOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
      • 3.17.5     UROLOGICAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
      • 3.17.6     ENT ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
      • 3.17.7     GASTROINTESTINAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
      • 3.17.8     GYNECOLOGY ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
      • 3.17.9     NEUROENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
    • 3.18     ENDOSCOPY DEVICES COMPANY COMPARISON TABLE BY REVENUE, PRODUCT, PRODUCT TYPE, AND APPLICATION
  • 4     ENDOSCOPY DEVICES GLOBAL MARKET, BY APPLICATIONS
    • 4.1     INTRODUCTION
    • 4.2     ARTHROSCOPY
      • 4.2.1     INTRODUCTION
      • 4.2.2     KNEE ARTHROSCOPY
      • 4.2.3     SHOULDER ARTHROSCOPY
      • 4.2.4     WRIST ARTHROSCOPY
      • 4.2.5     ANKLE ARTHROSCOPY
      • 4.2.6     ELBOW ARTHROSCOPY
      • 4.2.7     HIP ARTHROSCOPY
      • 4.2.8     OTHER ARTHROSCOPY PROCEDURES
    • 4.3     PULMONARY ENDOSCOPY
      • 4.3.1     INTRODUCTION
      • 4.3.2     BRONCHOSCOPY
      • 4.3.3     THORACOSCOPY
      • 4.3.4     MEDIASTINOSCOPY
    • 4.4     ENT ENDOSCOPY
      • 4.4.1     INTRODUCTION
      • 4.4.2     NASAL ENDOSCOPY
      • 4.4.3     LARYNGOSCOPY
      • 4.4.4     OTOENDOSCOPY
      • 4.4.5     TRANSNASAL ENDOSCOPY
    • 4.5     GASTROINTESTINAL ENDOSCOPY
      • 4.5.1     INTRODUCTION
      • 4.5.2     ESOPHAGOGASTRODUODENOSCOPY
      • 4.5.3     ENTEROSCOPY
      • 4.5.4     COLONOSCOPY
      • 4.5.5     SIGMOIDOSCOPY
      • 4.5.6     PROCTOSCOPY
      • 4.5.7     CHOLANGIOPANCREATOSCOPY
    • 4.6     GYNECOLOGY/OBSTETRICS
      • 4.6.1     INTRODUCTION
      • 4.6.2     HYSTEROSCOPY
      • 4.6.3     COLPOSCOPY
      • 4.6.4     FALLOPOSCOPY
      • 4.6.5     OTHER GYNECOLOGY/OBSTETRICS ENDOSCOPY APPLICATIONS
    • 4.7     NEUROENDOSCOPY
      • 4.7.1     INTRODUCTION
      • 4.7.2     EPIDUROSCOPY OR SPINAL ENDOSCOPY
      • 4.7.3     INTRAVENTRICULAR NEUROENDOSCOPY
      • 4.7.4     TRANSCRANIAL NEUROENDOSCOPY
      • 4.7.5     TRANSNASAL NEUROENDOSCOPY
    • 4.8     UROLOGICAL ENDOSCOPY
      • 4.8.1     INTRODUCTION
      • 4.8.2     NEPHROSCOPY
      • 4.8.3     CYSTOSCOPY
      • 4.8.4     URETEROSCOPY
      • 4.8.5     RESECTOSCOPY
    • 4.9     LAPAROSCOPY
      • 4.9.1     INTRODUCTION
      • 4.9.2     LAPAROSCOPIC BARIATRIC SURGERY
      • 4.9.3     LAPAROSCOPIC CHOLECYSTECTOMY
      • 4.9.4     LAPAROSCPIC APPENDECTOMY
      • 4.9.5     LAPAROSCOPIC HERNIA REPAIR
      • 4.9.6     HAND ASSISTED LAPAROSCOPY
    • 4.10     OTHER ENDOSCOPY APPLICATIONS
  • 5     ENDOSCOPY DEVICES GLOBAL MARKET, BY PRODUCTS
    • 5.1     INTRODUCTION
    • 5.2     ENDOSCOPES
      • 5.2.1     RIGID ENDOSCOPES
      • 5.2.2     FLEXIBLE ENDOSCOPES
      • 5.2.3     ROBOT-ASSISTED ENDOSCOPES, AND AI ENHANCED ENDOSCOPES
      • 5.2.4     CAPSULE ENDOSCOPES
    • 5.3     ENDOSCOPIC INSTRUMENTS
      • 5.3.1     INTRODUCTION
      • 5.3.2     ENDOSCOPIC CAMERAS
      • 5.3.3     DIGITAL DOCUMENTATION SYSTEMS
      • 5.3.4     LIGHT SOURCES
      • 5.3.5     MONITORS, AND DISPLAY SYSTEMS
      • 5.3.6     VIDEO CONVERTERS, AND PROCESSORS
      • 5.3.7     FLUID MANAGEMENT SYSTEMS
      • 5.3.8     OTHER ENDOSCOPIC INSTRUMENTS
    • 5.4     ENDOSCOPIC ACCESSORIES
      • 5.4.1     BIOPSY FORCEPS
      • 5.4.2     GRASPERS, AND RETRACTORS
      • 5.4.3     SNARES
      • 5.4.4     TROCARS
      • 5.4.5     SURGICAL DISSECTORS
      • 5.4.6     OTHER ENDOSCOPIC ACCESSORIES
  • 6     ENDOSCOPY DEVICES GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     ENDOSCOPY AMBULATORY SURGERY CENTERS OR AMBULATORY ENDOSCOPY CENTERS
    • 6.4     ENDOSCOPY DIAGNOSTIC CENTERS
    • 6.5     OTHER END-USERS (OFFICE BASED ENDOSCOPY (OBE) SUITES, AND ACADEMIC, AND RESEARCH INSTITUTES)
  • 7     GLOBAL ENDOSCOPY PROCEDURAL VOLUME
    • 7.1     ENDOSCOPY - NUMBER OF PROCEDURES BY REGION
      • 7.1.1     GLOBAL ARTHROSCOPY PROCEDURAL VOLUME
      • 7.1.2     GLOBAL GASTROINTESTINAL ENDOSCOPY PROCEDURAL VOLUME
      • 7.1.3     GLOBAL COLONOSCOPY PROCEDURAL VOLUME
      • 7.1.4     GLOBAL UROLOGICAL ENDOSCOPY PROCEDURAL VOLUME
      • 7.1.5     GLOBAL LAPAROSCOPY PROCEDURAL VOLUME
      • 7.1.6     GLOBAL ENT ENDOSCOPY ROCEDURAL VOLUME
      • 7.1.7     GLOBAL PULMONARY ENDOSCOPY PROCEDURAL VOLUME
      • 7.1.8     GLOBAL NEUROENDOSCOPY PROCEDURAL VOLUME
  • 8     REGIONAL MARKET ANALYSIS
    • 8.1     INTRODUCTION
    • 8.2     NORTH AMERICA
      • 8.2.1     U.S.
      • 8.2.2     REST OF NORTH AMERICA
    • 8.3     EUROPE
      • 8.3.1     GERMANY
      • 8.3.2     FRANCE
      • 8.3.3     UNITED KINGDOM
      • 8.3.4     REST OF EUROPE
    • 8.4     ASIA-PACIFIC
      • 8.4.1     JAPAN
      • 8.4.2     CHINA
      • 8.4.3     INDIA
      • 8.4.4     REST OF ASIA-PACIFIC (APAC)
    • 8.5     REST OF THE WORLD (ROW)
      • 8.5.1     BRAZIL
      • 8.5.2     REST OF LATAM
      • 8.5.3     MIDDLE EAST & OTHERS
  • 9     COMPETITIVE LANDSCAPE
    • 9.1     INTRODUCTION
    • 9.2     PRODUCT APPROVAL
    • 9.3     PRODUCT LAUNCH
    • 9.4     ACQUISITIONS
    • 9.5     COLLABORATIONS
    • 9.6     OTHER DEVELOPMENTS
  • 10     MAJOR PLAYER PROFILES
    • 10.1     ARTHREX, INC.
      • 10.1.1     OVERVIEW
      • 10.1.2     FINANCIALS
      • 10.1.3     PRODUCT PORTFOLIO
      • 10.1.4     KEY DEVELOPMENTS
      • 10.1.5     BUSINESS STRATEGY
      • 10.1.6     SWOT ANALYSIS
    • 10.2     B. BRAUN MELSUNGEN AG
      • 10.2.1     OVERVIEW
      • 10.2.2     FINANCIALS
      • 10.2.3     PRODUCT PORTFOLIO
      • 10.2.4     KEY DEVELOPMENTS
      • 10.2.5     BUSINESS STRATEGY
      • 10.2.6     SWOT ANALYSIS
    • 10.3     BOSTON SCIENTIFIC CORPORATION
      • 10.3.1     OVERVIEW
      • 10.3.2     FINANCIALS
      • 10.3.3     PRODUCT PORTFOLIO
      • 10.3.4     KEY DEVELOPMENTS
      • 10.3.5     BUSINESS STRATEGY
      • 10.3.6     SWOT ANALYSIS
    • 10.4     FUJIFILM HOLDINGS CORPORATION
      • 10.4.1     OVERVIEW
      • 10.4.2     FINANCIALS
      • 10.4.3     PRODUCT PORTFOLIO
      • 10.4.4     KEY DEVELOPMENTS
      • 10.4.5     BUSINESS STRATEGY
      • 10.4.6     SWOT ANALYSIS
    • 10.5     HOYA CORPORATION (PENTAX MEDICAL)
      • 10.5.1     OVERVIEW
      • 10.5.2     FINANCIALS
      • 10.5.3     PRODUCT PORTFOLIO
      • 10.5.4     KEY DEVELOPMENTS
      • 10.5.5     BUSINESS STRATEGY
      • 10.5.6     SWOT ANALYSIS
    • 10.6     JOHNSON & JOHNSON
      • 10.6.1     OVERVIEW
      • 10.6.2     FINANCIALS
      • 10.6.3     PRODUCT PORTFOLIO
      • 10.6.4     KEY DEVELOPMENTS
      • 10.6.5     BUSINESS STRATEGY
      • 10.6.6     SWOT ANALYSIS
    • 10.7     KARL STORZ SE & CO. KG
      • 10.7.1     OVERVIEW
      • 10.7.2     FINANCIALS
      • 10.7.3     PRODUCT PORTFOLIO
      • 10.7.4     KEY DEVELOPMENTS
      • 10.7.5     BUSINESS STRATEGY
      • 10.7.6     SWOT ANALYSIS
    • 10.8     MEDTRONIC, PLC.
      • 10.8.1     OVERVIEW
      • 10.8.2     FINANCIALS
      • 10.8.3     PRODUCT PORTFOLIO
      • 10.8.4     KEY DEVELOPMENTS
      • 10.8.5     BUSINESS STRATEGY
      • 10.8.6     SWOT ANALYSIS
    • 10.9     OLYMPUS CORPORATION
      • 10.9.1     OVERVIEW
      • 10.9.2     FINANCIALS
      • 10.9.3     PRODUCT PORTFOLIO
      • 10.9.4     KEY DEVELOPMENTS
      • 10.9.5     BUSINESS STRATEGY
      • 10.9.6     SWOT ANALYSIS
    • 10.10     STRYKER CORPORATION
      • 10.10.1     OVERVIEW
      • 10.10.2     FINANCIALS
      • 10.10.3     PRODUCT PORTFOLIO
      • 10.10.4     KEY DEVELOPMENTS
      • 10.10.5     BUSINESS STRATEGY
      • 10.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 2     ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION (2020-2028) ($MN)
      • TABLE 3     ARTHROSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 4     ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN)
      • TABLE 5     KNEE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN)
      • TABLE 6     SHOULDER ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 7     WRIST ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 8     ANKLE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 9     ELBOW ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 10     HIP ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 11     OTHER ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 12     PULMONARY ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 13     PULMONARY ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 14     BRONCHOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 15     THORACOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 16     MEDIASTINOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 17     ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 18     ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 19     NASAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 20     LARYNGOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 21     OTOENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 22     TRANSNASAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 23     GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 24     GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 25     ESOPHAGOGASTRODUODENOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 26     ENTEROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 27     COLONOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 28     SIGMOIDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 29     PROCTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 30     CHOLANGIOPANCREATOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 31     GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 32     GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 33     HYSTEROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 34     COLPOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 35     FALLOPOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 36     OTHER GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 37     NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 38     NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 39     SPINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 40     INTRAVENTRICULAR NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 41     TRANSCRANIAL NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 42     TRANSNASAL NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 43     UROLOGICAL ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 44     UROLOGICAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 45     NEPHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 46     CYSTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 47     URETEROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 48     RESECTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 49     LAPAROSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 50     LAPAROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 51     LAPAROSCOPIC BARIATRIC SURGERY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 52     LAPAROSCOPIC CHOLECYSTECTOMY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 53     APPENDECTOMY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 54     LAPAROSCOPIC HERNIA REPAIR GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 55     HAND ASSISTED LAPAROSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 56     OTHER ENDOSCOPY APPLICATIONS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 57     ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 58     ENDOSCOPES GLOBAL MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 59     ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 60     RIGID ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 61     FLEXIBLE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 62     ROBOT-ASSISTED ENDOSCOPES AND AI ENHANCED ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 63     CAPSULE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 64     ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 65     ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 66     ENDOSCOPIC CAMERAS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 67     DIGITAL DOCUMENTATION SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 68     LIGHT SOURCES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 69     MONITORS AND DISPLAY SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 70     VIDEO CONVERTERS AND PROCESSORS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 71     FLUID MANAGEMENT SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 72     OTHER ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 73     ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
      • TABLE 74     ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 75     BIOPSY FORCEPS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 76     GRASPERS AND RETRACTORS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 77     SNARES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 78     TROCARS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 79     SURGICAL DISSECTORS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 80     OTHER ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 81     ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
      • TABLE 82     HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 83     ENDOSCOPY AMBULATORY SURGERY CENTERS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 84     ENDOSCOPY DIAGNOSTIC CENTRES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 85     OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 86     GLOBAL ARTHROSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
      • TABLE 87     GLOBAL GASTROINTESTINAL ENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
      • TABLE 88     GLOBAL COLONOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
      • TABLE 89     GLOBAL UROLOGY ENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
      • TABLE 90     GLOBAL LAPAROSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
      • TABLE 91     GLOBAL ENT ENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
      • TABLE 92     GLOBAL PULMONARY ENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
      • TABLE 93     GLOBAL NEUROENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
      • TABLE 94     ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • TABLE 95     NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY, (2020-2028) ($MN)
      • TABLE 96     NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
      • TABLE 97     NORTH AMERICA ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 98     NORTH AMERICA LAPAROSCOPY MARKET REVENUE, BY ANATOMY(2020-2028) ($MN)
      • TABLE 99     NORTH AMERICA PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 100     NORTH AMERICA ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 101     NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 102     NORTH AMERICA GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 103     NORTH AMERICA NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 104     NORTH AMERICA UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 105     NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 106     NORTH AMERICA ENDOSCOPES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
      • TABLE 107     NORTH AMERICA ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
      • TABLE 108     NORTH AMERICA ENDOSCOPY ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
      • TABLE 109     NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
      • TABLE 110     EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY, (2020-2028) ($MN)
      • TABLE 111     EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
      • TABLE 112     EUROPE ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 113     EUROPE LAPAROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 114     EUROPE PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 115     EUROPE ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 116     EUROPE UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY(2020-2028) ($MN)
      • TABLE 117     EUROPE NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 118     EUROPE GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 119     EUROPE GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 120     EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 121     EUROPE ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 122     EUROPE ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 123     EUROPE ENDOSCOPIC ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
      • TABLE 124     EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
      • TABLE 125     ASIA-PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY (2020-2028) ($MN)
      • TABLE 126     ASIA-PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
      • TABLE 127     ASIA-PACIFIC ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 128     ASIA-PACIFIC LAPAROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 129     ASIA-PACIFIC PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 130     ASIA-PACIFIC ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 131     ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 132     ASIA-PACIFIC GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 133     ASIA-PACIFIC NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY(2020-2028) ($MN)
      • TABLE 134     ASIA-PACIFIC UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 135     ASIA PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 136     ASIA-PACIFIC ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 137     ASIA-PACIFIC ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 138     ASIA PACIFIC ENDOSCOPY ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
      • TABLE 139     ASIA-PACIFIC ENDOSCOPY MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
      • TABLE 140     REST OF THE WORLD ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY (2020-2028) ($MN)
      • TABLE 141     ROW ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
      • TABLE 142     ROW ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 143     ROW LAPAROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 144     ROW PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 145     ROW ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 146     ROW UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 147     ROW NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 148     ROW GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 149     ROW GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
      • TABLE 150     ROW ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 151     ROW ENDOSCOPES MARKET REVENUE, BY PRODUCTS(2020-2028) ($MN)
      • TABLE 152     ROW ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
      • TABLE 153     ROW ENDOSCOPY ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
      • TABLE 154     ROW ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
      • TABLE 155     PRODUCT APPROVALS (2020-2021)
      • TABLE 156     PRODUCT LAUNCH (2020-2021)
      • TABLE 157     ACQUISITIONS (2020-2021)
      • TABLE 158     COLLABORATIONS, (2020-2021)
      • TABLE 159     OTHER DEVELOPMENTS (2020-2021)
      • TABLE 160     B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES (2018-2020) ($MN)
      • TABLE 161     B.BRAUN MELSUNGEN AG: TOTAL REVENUE BY SEGMENTS (2018-2020) ($MN)
      • TABLE 162     B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 163     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q2) ($MN)
      • TABLE 164     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2019-2021) (Q2) ($MN)
      • TABLE 165     BOSTON SCIENTIFIC CORPORATION: MEDSURG TOTAL REVENUE, BY SUB-SEGMENTS, (2019-2021) (Q2) ($MN)
      • TABLE 166     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY (2019-2021) (Q2) ($MN)
      • TABLE 167     FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2019-2021) (Q1) ($MN)
      • TABLE 168     FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2019-2021) (Q1) ($MN)
      • TABLE 169     FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY REGION (2019-2021) (Q1) ($MN)
      • TABLE 170     HOYA CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q1) ($MN)
      • TABLE 171     HOYA CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2019-2021) (Q1) ($MN)
      • TABLE 172     HOYA CORPORATION: LIFE CARE SEGMENT TOTAL REVENUE, BY SUB-SEGMENTS, (2019-2021) (Q1) ($MN)
      • TABLE 173     HOYA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q1) ($MN)
      • TABLE 174     JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES (2019-2021) (Q2) ($MN)
      • TABLE 175     JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS (2019-2021) (Q2) ($MN)
      • TABLE 176     JOHNSON & JOHNSON: MEDICAL DEVICES REVENUE, BY SUB-SEGMENTS (2019-2021) (Q2) ($MN)
      • TABLE 177     JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY (2019-2021) (Q2) ($MN)
      • TABLE 178     MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES (2019-2021) (Q1) ($MN)
      • TABLE 179     MEDTRONIC PLC : TOTAL REVENUE, BY SEGMENTS (2019-2021) (Q1) ($MN)
      • TABLE 180     MEDTRONIC PLC : MEDICAL SURGICAL REVENUE, BY SUB-SEGMENTS (2019-2021) (Q1) ($MN)
      • TABLE 181     MEDTRONIC PLC : NEUROSCIENCE REVENUE, BY SUB-SEGMENTS (2019-2021) (Q1) ($MN)
      • TABLE 182     MEDTRONIC PLC : TOTAL REVENUE, BY GEOGRAPHY (2019-2021) (Q1) ($MN)
      • TABLE 183     OLYMPUS CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q1) ($MN)
      • TABLE 184     OLYMPUS CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2019-2021) (Q1) ($MN)
      • TABLE 185     OLYMPUS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q1) ($MN)
      • TABLE 186     STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q1) ($MN)
      • TABLE 187     STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2019-2021) (Q1) ($MN)
      • TABLE 188     STRYKER CORPORATION: MEDSURG TOTAL REVENUE, BY SUB-SEGMENTS, (2019-2021) (Q1) ($MN)
      • TABLE 189     STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q1) ($MN)

      LIST OF FIGURES

      • FIGURE 1     ENDOSCOPY DEVICES GLOBAL MARKET REVENUE AND MARKET SHARE, BY REGION (2020-2028) ($MN)
      • FIGURE 2     ENDOSCOPY DEVICES GLOBAL MARKET: RESEARCH APPROACH
      • FIGURE 3     ENDOSCOPY DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     ENDOSCOPY DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     ENDOSCOPY DEVICES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     ENDOSCOPY DEVICES GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     ENDOSCOPY DEVICES GLOBAL MARKET: APPLICATION MARKET SEGMENTATION
      • FIGURE 8     MARKET DYNAMICS
      • FIGURE 9     ENDOSCOPY DEVICES CLINICAL TRIAL ANALYSIS
      • FIGURE 10     ENDOSCOPY DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2017-2021)
      • FIGURE 11     ENDOSCOPY DEVICES MARKET: PORTER’S ANALYSIS
      • FIGURE 12     ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
      • FIGURE 13     ARTHROSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
      • FIGURE 14     PULMONARY ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
      • FIGURE 15     LAPAROSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
      • FIGURE 16     UROLOGICAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
      • FIGURE 17     ENT ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS2021(%)
      • FIGURE 18     GI ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
      • FIGURE 19     GYNECOLOGY ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (%)
      • FIGURE 20     NEUROENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (%)
      • FIGURE 21     ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY APPLICATION (2021) (%)
      • FIGURE 22     ARTHROSCOPY DEVICES GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 23     HIP ARTHROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 24     PULMONARY ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 25     ENT ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY, (2021 VS 2028) (%)
      • FIGURE 26     NASAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 27     GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 28     ENTEROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 29     COLONOSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 30     SIGMOIDOSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 31     CHOLANGIOPANCREATOSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 32     GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 33     HYSTEROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 34     NEUROENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 35     UROLOGICAL ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 36     URETEROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 37     LAPAROSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 38     ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
      • FIGURE 39     ENDOSCOPES GLOBAL MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
      • FIGURE 40     FLEXIBLE ENDOSCOPES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 41     ENDOSCOPIC INSTRUMENTS GLOBAL MARKET SHARE, BY PRODUCT, (2021 VS 2028) (%)
      • FIGURE 42     ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2021 VS 2028) (%)
      • FIGURE 43     MONITORS AND DISPLAY UNITS GLOBAL MARKET REVENUE, BY REGION (2021 VS 2028) (%)
      • FIGURE 44     ENDOSCOPY ACCESSORIES GLOBAL MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
      • FIGURE 45     ENDOSCOPY ACCESSORIES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 46     BIOPSY FORCEPS GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 47     GRASPERS AND RETRACTORS GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 48     SNARES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 49     OTHER ENDOSCOPIC ACCESSORIES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
      • FIGURE 50     ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY END-USERS (2021 VS 2028)(%)
      • FIGURE 51     GLOBAL ENDOSCOPY PROCEDURAL VOLUME (NO’S)(MN)
      • FIGURE 52     GLOBAL ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028) NO’S (MN)
      • FIGURE 53     GLOBAL ENDOSCOPY DEVICES MARKET REVENUE, BY REGION (2020-2028) ($MN)
      • FIGURE 54     GLOBAL ENDOSCOPY DEVICES MARKET SHARE, BY REGION (2021) (%)
      • FIGURE 55     NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY, (2021 VS 2028) (%)
      • FIGURE 56     NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) & CAGR (%)
      • FIGURE 57     NORTH AMERICA ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 58     NORTH AMERICA LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 59     NORTH AMERICA PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 60     NORTH AMERICA ENT ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 61     NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 62     NORTH AMERICA GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 63     NORTH AMERICA NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 64     NORTH AMERICA UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 65     NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
      • FIGURE 66     NORTH AMERICA ENDOSCOPES MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
      • FIGURE 67     NORTH AMERICA ENDOSCOPIC INSTRUMENTS MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
      • FIGURE 68     NORTH AMERICA PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2021 VS 2028) ($MN)
      • FIGURE 69     NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
      • FIGURE 70     NORTH AMERICA ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028), NO’S (MN)
      • FIGURE 71     U.S. ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 72     U.S. ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 73     U.S ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 74     REST OF NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028)($MN)
      • FIGURE 75     REST OF NORTH AMERICA ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS(2021 VS 2028) ($MN)
      • FIGURE 76     REST OF NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 77     EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY, (2021 VS 2028) (%)
      • FIGURE 78     EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) & CAGR (%)
      • FIGURE 79     EUROPE ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 80     EUROPE LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 81     EUROPE PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2021 VS 2028) ($MN)
      • FIGURE 82     EUROPE ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2021 VS 2028) ($MN)
      • FIGURE 83     EUROPE UROLOGICAL ENDOSCOPY MARKET SHARE BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 84     EUROPE NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 85     EUROPE GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 86     EUROPE GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 87     EUROPE ENDOSCOPY DEVICES MARKET BY PRODUCTS, (2021 VS 2028) (%)
      • FIGURE 88     EUROPE ENDOSCOPES MARKET SHARE, BY PRODUCTS, (2021 VS 2028) (%)
      • FIGURE 89     EUROPE ENDOSCOPY INSTRUMENTS MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
      • FIGURE 90     EUROPE ENDOSCOPIC ACCESSORIES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
      • FIGURE 91     EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY END-USER (2021 VS 2028) (%)
      • FIGURE 92     EUROPE ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028) NO’S, (MN)
      • FIGURE 93     GERMANY ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 94     GERMANY ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 95     GERMANY ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 96     FRANCE ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028)($MN)
      • FIGURE 97     FRANCE ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 98     FRANCE ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028)($MN)
      • FIGURE 99     U.K. ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028)($MN)
      • FIGURE 100     U.K. ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 101     U.K. ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 102     REST OF EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028)($MN)
      • FIGURE 103     REST OF EUROPE ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 104     REST OF EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 105     ASIA PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY (2021 VS 2028) (%)
      • FIGURE 106     ASIA PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) (CAGR) (%)
      • FIGURE 107     ASIA-PACIFIC ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 108     ASIA-PACIFIC LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 109     ASIA-PACIFIC PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 110     ASIA PACIFIC ENT ENDOSCOPY MARKETSHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 111     ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 112     ASIA PACIFIC GYNAECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 113     ASIA PACIFIC NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 114     ASIA-PACIFIC UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 115     ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
      • FIGURE 116     ASIA-PACIFIC ENDOSCOPES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
      • FIGURE 117     ASIA PACIFIC ENDOSCOPIC INSTRUMENTS MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
      • FIGURE 118     ASIA PACIFIC ENDOSCOPY ACCESSORIES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
      • FIGURE 119     ASIA PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY END-USERS(2021 VS 2028) (%)
      • FIGURE 120     ASIA PACIFIC ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028) NO’S (MN)
      • FIGURE 121     JAPAN ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 122     JAPAN ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 123     JAPAN ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 124     CHINA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 125     CHINA ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 126     CHINA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 127     INDIA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 128     INDIA ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 129     INDIA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 130     REST OF APAC ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028)($MN)
      • FIGURE 131     REST OF APAC ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 132     REST OF APAC ENDOSCOPY MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 133     REST OF THE WORLD ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY (2020 VS 2028) (%)
      • FIGURE 134     ROW ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) (CAGR) (%)
      • FIGURE 135     ROW ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 136     ROW LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 137     ROW PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 138     ROW ENT ENDOSCOPY DEVICES MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 139     ROW UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 140     ROW NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 141     ROW GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 142     ROW GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
      • FIGURE 143     ROW ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
      • FIGURE 144     ROW ENDOSCOPES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
      • FIGURE 145     ROW ENDOSCOPIC INSTRUMENTS MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
      • FIGURE 146     ROW ENDOSCOPIC ACCESSORIES MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
      • FIGURE 147     ROW ENDOSCOPY MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
      • FIGURE 148     ROW ENDOSCOPY PROCEDURE VOLUME (2021 VS 2028), NO’S (MN)
      • FIGURE 149     BRAZIL ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 150     BRAZIL ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 151     BRAZIL ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 152     REST OF LATAM ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 153     REST OF LATAM ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 154     REST OF LATAM ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 155     MIDDLE EAST & OTHERS ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
      • FIGURE 156     MIDDLE EAST & OTHERS ENDOSCOPY DEVICES AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
      • FIGURE 157     MIDDLE EAST & OTHERS ENDOSCOPY MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
      • FIGURE 158     KEY GROWTH STRATEGIES, (2020-2021)
      • FIGURE 159     SWOT: ARTHREX, INC.
      • FIGURE 160     SWOT: B.BRAUN MELSUNGEN AG
      • FIGURE 161     SWOT: BOSTON SCIENTIFIC CORPORATION
      • FIGURE 162     SWOT: FUJIFILM HOLDINGS CORPORATION
      • FIGURE 163     SWOT: HOYA CORPORATION (PENTAX MEDICAL)
      • FIGURE 164     SWOT: JOHNSON & JOHNSON
      • FIGURE 165     SWOT: KARL STORZ SE & CO. KG
      • FIGURE 166     SWOT: MEDTRONIC PLC
      • FIGURE 167     SWOT: OLYMPUS CORPORATION
      • FIGURE 168     SWOT: STRYKER CORPORATION

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     3NT Medical Ltd.
      • 2     ACE Medical Devices Pvt. Ltd.
      • 3     Ackermann Instrumente GmbH
      • 4     Acteon Group (Comeg Medical Technologies)
      • 5     Adeor Medical AG
      • 6     Alltion Co., Ltd.
      • 7     Ambu A/S
      • 8     American Medical Endoscopy
      • 9     Anika Therapeutics, Inc.
      • 10     AnX Robotica Corporation
      • 11     Aohua Endoscope Co. Ltd.
      • 12     Arthrex, Inc.
      • 13     B.Braun Melsungen AG
      • 14     Biop Medical
      • 15     Bolton Surgical Limited
      • 16     Boston Scientific Corporation
      • 17     Bridgemaster Medical
      • 18     BriteMed Technology Inc.
      • 19     Canady Life Sciences (Endocontrol SA)
      • 20     Chongqing Jinshan Science & Technology (Group) Co., Ltd
      • 21     Conmed Corporation
      • 22     Contact Co. LLC.
      • 23     Cook Group
      • 24     CooperSurgical, Inc.
      • 25     Cosmo Pharmaceuticals NV
      • 26     DEWIMED Medizintechnik GmbH (REMA Medizintechnik GmbH)
      • 27     Efer Endoscopy
      • 28     Eizo Corporation
      • 29     Electro Medical Systems
      • 30     EMOS Technology GmbH
      • 31     ENDO Indonesia, PT
      • 32     ENDOLOOK (Endoservice GmbH)
      • 33     EndoMaster Pte. Ltd.
      • 34     ERA Endoscopy SRL
      • 35     Erbe Elektromedizin GmbH
      • 36     EvoEndo Inc.
      • 37     Fannin Ltd.
      • 38     Firefly Global
      • 39     Frankenman International, Ltd
      • 40     Fujifilm Holdings Corporation
      • 41     GI View Ltd.
      • 42     Gimmi GmbH
      • 43     Gulf Fiberoptics Group
      • 44     Happersberg Otopront GmbH
      • 45     Heine Optotechnik GmbH & CO. KG
      • 46     Hill-Rom Services, Inc.
      • 47     Hobbs Medical, Inc
      • 48     Hologic, Inc.
      • 49     Hoogland Spine Products GmbH
      • 50     Hoya Corporation
      • 51     Hunan Vathin Medical Instrument Co., Ltd.
      • 52     Ilo Electronic, GmbH
      • 53     Inka Surgical Instruments
      • 54     Integrated Endoscopy
      • 55     Intromedic
      • 56     Intuitive surgical, Inc.
      • 57     Jiangsu Brightness Medical Device Co., Ltd.
      • 58     Jinshan Science & Technology (Group) Co., Ltd.
      • 59     Johnson & Johnson
      • 60     Joimax GmbH
      • 61     Karl Storz SE CO. & KG
      • 62     Laborie (Cogentix Medical)
      • 63     Lagis Enterprise Co., Ltd
      • 64     Laprosurge, Ltd
      • 65     LeMaitre Vascular, Inc.
      • 66     LiNA Medical
      • 67     Locamed Ltd
      • 68     Machida endoscope Co. Ltd
      • 69     Medgyn Product, Inc
      • 70     Medicon
      • 71     Mediflex Surgical
      • 72     Medigus Ltd.
      • 73     MEDIT Inc.
      • 74     Medrobotics Corporation
      • 75     Medtronic, PLC
      • 76     Merit Medical Systems Inc.
      • 77     Microsoft Corporation
      • 78     Mobile ODT
      • 79     NEC Corporation
      • 80     Novanta Inc. (NDS surgical imaging)
      • 81     Novaprobe Inc.
      • 82     Olympus Corporation
      • 83     Om Surgicals
      • 84     OmniVision Technologies, Inc.
      • 85     Ophit Co.Ltd.
      • 86     Optomic
      • 87     Oravu
      • 88     Orpheus-medical Ltd
      • 89     Ovesco endoscopy AG
      • 90     Palliare Ltd.
      • 91     Parburch medical
      • 92     Perioendoscopy LLC
      • 93     Prosurg Inc.
      • 94     Provix
      • 95     Purple Surgical International Ltd.
      • 96     Richard wolf GmbH
      • 97     Rocket medical PLC
      • 98     Roper Technologies Inc. (Verathon Inc.)
      • 99     Rudolf Medical GmbH & Co. KG.
      • 100     Schindler Endoskopie Technologie GmbH
      • 101     Scholly Fiberoptic GmbH
      • 102     Schott AG
      • 103     Shanghai MicroPort Medical Co., Ltd
      • 104     Shenyang Shenda Endoscope Co. Ltd.
      • 105     Sklar Surgical Instruments
      • 106     Smart Medical Systems Ltd.
      • 107     Smith & Nephew PLC
      • 108     Solos Endoscopy
      • 109     SonoScape Medical Corp.
      • 110     Steris Corporation
      • 111     Stryker Corporation
      • 112     Tekno-Medical Optik-Chirurgic GmbH
      • 113     Timesco
      • 114     Trice Medical
      • 115     UnivLabs Technologies Pvt Ltd
      • 116     UroViu Corporation
      • 117     Utah medical (Femcare-Nikomed)
      • 118     Uvision360
      • 119     Vimex endoscopy
      • 120     Visionscope technologies, LLC
      • 121     W.O.M. WORLD OF MEDICINE GmbH
      • 122     WISAP medical technology
      • 123     Xenocor Inc.
      • 124     Xion GmbH
      • 125     Zest Dental Solutions
      • 126     Zumax Medical Medical Co. Ltd.